DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
VERDINEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VERDINEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
85Q03215IW
Molecule Type:
Small molecule
Molecular Formula:
C18H12F6N6O
Molecular Weight:
442.32
AlogP:
3.99
PSA:
84.73
HBD:
2.0
HBA:
#RotB:
5.0
Source:
VS-5584
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Mesothelioma
PI3-kinase class I inhibitor
VS-5584
×
Maximum Phase:
1
First Approval:
None
UNII:
W71J4X250V
Molecule Type:
Small molecule
Molecular Formula:
C21H14F2N6O2
Molecular Weight:
420.38
AlogP:
3.11
PSA:
90.62
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ABTL-0812
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ABTL-0812
×
Maximum Phase:
1
First Approval:
None
UNII:
0DE74TJ7EZ
Molecule Type:
Small molecule
Molecular Formula:
C18H32O3
Molecular Weight:
296.45
AlogP:
4.86
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
14.0
Source:
CYC-116
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
CYC-116
×
Maximum Phase:
1
First Approval:
None
UNII:
YAX4981K2D
Molecule Type:
Small molecule
Molecular Formula:
C18H20N6OS
Molecular Weight:
368.47
AlogP:
3.07
PSA:
89.19
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PCO-371
1
Small molecule
Investigational
Unknown
Unknown
Hypoparathyroidism
Unknown
PCO-371
×
Maximum Phase:
1
First Approval:
None
UNII:
TE53TU0WSQ
Molecule Type:
Small molecule
Molecular Formula:
C29H32F3N5O6S
Molecular Weight:
635.67
AlogP:
3.32
PSA:
137.48
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ORDOPIDINE
1
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Dopamine D2 receptor modulator
ORDOPIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
0P43SIA7J6
Molecule Type:
Small molecule
Molecular Formula:
C14H20FNO2S
Molecular Weight:
285.38
AlogP:
2.43
PSA:
37.38
HBD:
0.0
HBA:
#RotB:
3.0
Source:
LECOZOTAN
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
LECOZOTAN
×
Maximum Phase:
1
First Approval:
None
UNII:
48854OTZ5E
Molecule Type:
Small molecule
Molecular Formula:
C28H29N5O3
Molecular Weight:
483.57
AlogP:
3.58
PSA:
81.93
HBD:
0.0
HBA:
#RotB:
6.0
Source:
PLX8394
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PLX8394
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
YTTRIUM Y-90
1
Small molecule
Investigational
Unknown
Unknown
Neoplasm Metastasis; Neoplasms; Bile Duct Neoplasms; Cholangiocarcinoma
Unknown
YTTRIUM Y-90
×
Maximum Phase:
1
First Approval:
None
UNII:
1K8M7UR6O1
Molecule Type:
Small molecule
Molecular Formula:
Y
Molecular Weight:
89.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PUQUITINIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PUQUITINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
WFG29AB872
Molecule Type:
Small molecule
Molecular Formula:
C17H15N7
Molecular Weight:
317.36
AlogP:
3.22
PSA:
91.41
HBD:
3.0
HBA:
#RotB:
4.0
Source:
AVL-3288
1
Small molecule
Investigational
Unknown
Unknown
Psychotic Disorders; Schizophrenia
Neuronal acetylcholine receptor protein alpha-7 subunit positive allosteric modulator
AVL-3288
×
Maximum Phase:
1
First Approval:
None
UNII:
VA80VAX4WF
Molecule Type:
Small molecule
Molecular Formula:
C19H15Cl2N3O2
Molecular Weight:
388.25
AlogP:
5.38
PSA:
67.16
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ASTAXANTHIN
1
Small molecule
Investigational
Unknown
Unknown
Metabolic Syndrome; Diabetic Neuropathies; Osteoarthritis, Knee
Antioxidant, anti-inflammatory and antiapoptotic activities
ASTAXANTHIN
×
Maximum Phase:
1
First Approval:
None
UNII:
8XPW32PR7I
Molecule Type:
Small molecule
Molecular Formula:
C40H52O4
Molecular Weight:
596.85
AlogP:
8.91
PSA:
74.6
HBD:
2.0
HBA:
#RotB:
10.0
Source:
GIMATECAN
1
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Myelodysplastic Syndromes; Neoplasms; Pancreatic Neoplasms; Small Cell Lung Carcinoma
DNA topoisomerase I inhibitor
GIMATECAN
×
Maximum Phase:
1
First Approval:
None
UNII:
7KKS9R192F
Molecule Type:
Small molecule
Molecular Formula:
C25H25N3O5
Molecular Weight:
447.49
AlogP:
3.23
PSA:
103.01
HBD:
1.0
HBA:
#RotB:
3.0
Source:
SERIDOPIDINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Dopamine D2 receptor modulator
SERIDOPIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
1359K87ZYE
Molecule Type:
Small molecule
Molecular Formula:
C14H20FNO2S
Molecular Weight:
285.38
AlogP:
2.43
PSA:
37.38
HBD:
0.0
HBA:
#RotB:
3.0
Source:
CAFUSERTIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Neoplasms
Serine/threonine-protein kinase PLK1 inhibitor
CAFUSERTIB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HKI-357
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HKI-357
×
Maximum Phase:
1
First Approval:
None
UNII:
39R3638KZ6
Molecule Type:
Small molecule
Molecular Formula:
C31H29ClFN5O3
Molecular Weight:
574.06
AlogP:
6.68
PSA:
99.51
HBD:
2.0
HBA:
#RotB:
11.0
Source:
CINOBUFOTALIN
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CINOBUFOTALIN
×
Maximum Phase:
1
First Approval:
None
UNII:
L0QBZ37386
Molecule Type:
Small molecule
Molecular Formula:
C26H34O7
Molecular Weight:
458.55
AlogP:
2.91
PSA:
109.5
HBD:
2.0
HBA:
#RotB:
2.0
Source:
GSK-945237
1
Small molecule
Investigational
Unknown
Unknown
Infections
Unknown
GSK-945237
×
Maximum Phase:
1
First Approval:
None
UNII:
U9T63BZ3AS
Molecule Type:
Small molecule
Molecular Formula:
C24H26FN5O3
Molecular Weight:
451.5
AlogP:
2.05
PSA:
81.51
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CS-8080
1
Small molecule
Investigational
Unknown
Unknown
Unknown
LXR-alpha agonist
CS-8080
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
H-100
1
Small molecule
Investigational
Unknown
Unknown
Penile Induration
Unknown
H-100
×
Maximum Phase:
1
First Approval:
None
UNII:
5RQ73K2EC8
Molecule Type:
Small molecule
Molecular Formula:
C11H11N3O3
Molecular Weight:
233.23
AlogP:
0.44
PSA:
102.22
HBD:
3.0
HBA:
#RotB:
5.0
Source:
RIMEPORIDE
1
Small molecule
Investigational
Unknown
Unknown
Muscular Dystrophy, Duchenne
Unknown
RIMEPORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
QH6B4V5743
Molecule Type:
Small molecule
Molecular Formula:
C11H15N3O5S2
Molecular Weight:
333.39
AlogP:
-0.57
PSA:
147.25
HBD:
3.0
HBA:
#RotB:
3.0
Source:
LUFOTRELVIR
1
Small molecule
Investigational
Unknown
Unknown
COVID-19; Virus Diseases; Severe Acute Respiratory Syndrome
Unknown
LUFOTRELVIR
×
Maximum Phase:
1
First Approval:
None
UNII:
XJ51YOB1SC
Molecule Type:
Small molecule
Molecular Formula:
C24H33N4O9P
Molecular Weight:
552.52
AlogP:
1.01
PSA:
196.15
HBD:
6.0
HBA:
#RotB:
13.0
Source:
ALETHINE
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Multiple Myeloma
Unknown
ALETHINE
×
Maximum Phase:
1
First Approval:
None
UNII:
LY583605Y8
Molecule Type:
Small molecule
Molecular Formula:
C10H22N4O2S2
Molecular Weight:
294.45
AlogP:
-0.7
PSA:
110.24
HBD:
4.0
HBA:
#RotB:
11.0
Source:
IMD-2560
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor
IMD-2560
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CUDC-101
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Liver Neoplasms; Neoplasms; Stomach Neoplasms
Epidermal growth factor receptor erbB1 inhibitor
CUDC-101
×
Maximum Phase:
1
First Approval:
None
UNII:
1A7Y9MP123
Molecule Type:
Small molecule
Molecular Formula:
C24H26N4O4
Molecular Weight:
434.5
AlogP:
4.2
PSA:
105.6
HBD:
3.0
HBA:
#RotB:
11.0
Source:
LB-102
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
LB-102
×
Maximum Phase:
1
First Approval:
None
UNII:
N81WKW91XF
Molecule Type:
Small molecule
Molecular Formula:
C18H29N3O4S
Molecular Weight:
383.51
AlogP:
1.74
PSA:
87.74
HBD:
2.0
HBA:
#RotB:
8.0
Source:
RALANITEN ACETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RALANITEN ACETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
L10K286T2H
Molecule Type:
Small molecule
Molecular Formula:
C27H33ClO8
Molecular Weight:
521.01
AlogP:
4.44
PSA:
97.36
HBD:
0.0
HBA:
#RotB:
13.0
Source:
HYODEOXYCHOLIC_ACID
1
Small molecule
Investigational
Unknown
Unknown
Hypercholesterolemia
LXR-alpha agonist
HYODEOXYCHOLIC_ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
7A33Y6EHYK
Molecule Type:
Small molecule
Molecular Formula:
C24H40O4
Molecular Weight:
392.58
AlogP:
4.48
PSA:
77.76
HBD:
3.0
HBA:
#RotB:
4.0
Source:
GSK-461364
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
Serine/threonine-protein kinase PLK1 inhibitor
GSK-461364
×
Maximum Phase:
1
First Approval:
None
UNII:
8QO27TK6Q4
Molecule Type:
Small molecule
Molecular Formula:
C27H28F3N5O2S
Molecular Weight:
543.62
AlogP:
5.09
PSA:
76.62
HBD:
1.0
HBA:
#RotB:
7.0
Source:
VINPOCETINE
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy; Diabetic Nephropathies; Attention Deficit Disorder with Hyperactivity
Unknown
VINPOCETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
543512OBTC
Molecule Type:
Small molecule
Molecular Formula:
C22H26N2O2
Molecular Weight:
350.46
AlogP:
4.15
PSA:
34.47
HBD:
0.0
HBA:
#RotB:
3.0
Source:
NKTR-171
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel alpha subunit blocker
NKTR-171
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELINOGREL
1
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases; Myocardial Infarction
Purinergic receptor P2Y12 antagonist
ELINOGREL
×
Maximum Phase:
1
First Approval:
None
UNII:
915Y8E749J
Molecule Type:
Small molecule
Molecular Formula:
C20H15ClFN5O5S2
Molecular Weight:
523.96
AlogP:
3.09
PSA:
142.16
HBD:
4.0
HBA:
#RotB:
5.0
Source:
PYRUVATE SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Asthma; Cystic Fibrosis; Severe Acute Respiratory Syndrome
Unknown
PYRUVATE SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
POD38AIF08
Molecule Type:
Small molecule
Molecular Formula:
C3H3NaO3
Molecular Weight:
110.04
AlogP:
-0.34
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
1.0
Source:
HE3235
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Androgen Receptor modulator
HE3235
×
Maximum Phase:
1
First Approval:
None
UNII:
891O182ZP5
Molecule Type:
Small molecule
Molecular Formula:
C21H32O2
Molecular Weight:
316.49
AlogP:
3.75
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
INDIBULIN
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms
Tubulin inhibitor
INDIBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
80K4H2RB8P
Molecule Type:
Small molecule
Molecular Formula:
C22H16ClN3O2
Molecular Weight:
389.84
AlogP:
4.56
PSA:
63.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
1
2
…
80
81
82
83
84
85
86
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA